摘要:
A toner is provided including a colorant; a binder resin (A) which is a polyester resin having no tetrahydrofuran insoluble component, and having a molecular weight distribution such that components having a molecular weight of not greater than 500 are included in an amount of not greater than 4% by weight and a peak is present in a molecular weight range of from 3,000 to 9,000 when measured by gel permeation chromatography (GPC); and a binder resin (B) which is a polyester resin having no tetrahydrofuran insoluble component, and including units of a polycarboxylic acid and a diol having the specific formula; wherein at least one of the binder resins (A) and (B) is prepared in the presence of the specific titanium-containing catalyst, and wherein a weight ratio ((A)/(B)) of the binder resin (A) to the binder resin (B) is from 60/40 to 85/15.
摘要:
A subject of the present invention is to provide a novel aromatic five- or six-memberd heterocyclic derivative having 4-pyridylalkylthio as a substituent or a salt thereof which is useful as a pharmaceutical. Compound represented by the following general formula [I] or salts thereof are useful as therapeutic agents for diseases in which angiogenesis or augmentation of vascular permeability is involved. In the formula, ring “A” is a benzene ring or an aromatic five- or six-memberd heterocycle which can be fused with a cycloalkane ring, “B” is alkylene, R1 and R2, the same or different, are H, OH, substituted or unsubstituted alkoxy and the like, X and Y, the same or different, are group(s) selected from H, halogen, OH, substituted or unsubstituted alkoxy and the like respectively, p is 0, 1 or 2, and q is 0 or 1.
摘要:
A toner is provided including a colorant; a binder resin (A) which is a polyester resin having no tetrahydrofuran insoluble component, and having a molecular weight distribution such that components having a molecular weight of not greater than 500 are included in an amount of not greater than 4% by weight and a peak is present in a molecular weight range of from 3,000 to 9,000 when measured by gel permeation chromatography (GPC); and a binder resin (B) which is a polyester resin having no tetrahydrofuran insoluble component, and including units of a polycarboxylic acid and a diol having the specific formula; wherein at least one of the binder resins (A) and (B) is prepared in the presence of the specific titanium-containing catalyst, and wherein a weight ratio ((A)/(B)) of the binder resin (A) to the binder resin (B) is from 60/40 to 85/15.
摘要:
An image forming apparatus including an image bearing member and a developing device configured to develop an electrostatic image on the image bearing member with a toner to form a toner image thereon and including a developing unit configured to develop the electrostatic image, and a toner cartridge configured to supply the toner to the developing unit through at least one opening, wherein the developing device circulates the toner between the toner cartridge and the developing unit through the at least one opening, and wherein the internal temperature of the hopper is higher than that of the cartridge and the ratio of a charge quantity distribution parameter of the toner under a condition of 45° C. and 54% RH to that under a condition of 25° C. and 54% RH is greater than 0.9 and less than 1.5.
摘要:
An image forming apparatus includes an image bearer, a developing unit configured to develop a latent image formed on the image bearer with a toner to form a toner image, and a transfer member including a contact area that comes in contact with the image bearer. The toner image is primary transferred from the image bearer to the transfer member. A speed difference between the image bearer and the transfer member at the contact area is 0.1% or greater but 0.8% or less. The toner has an average circularity of 0.971 or greater but 0.986 or less and a shape factor SF-2 of 110 or greater but 119 or less. The speed difference is represented by the following formula: Speed difference [%]={(V1−V2)/V2}×100 [Speed difference] where V1 is a linear speed of the image bearer, and V2 is a linear speed of the transfer member.
摘要:
A toner including: a binder resin containing a non-crystalline resin and a crystalline resin; a colorant; and, a releasing agent, wherein the releasing agent has a melting point of 55° C. to 80° C., and wherein the toner satisfies the following Expressions 1 and 2: (Expression 1): 20,000 Pa·s≦G1≦50,000 Pa·s; and (Expression 2): (G4/G2)/(G3/G1) 1.00, where G1 is a storage modulus, G2 is a loss modulus, G3 is a storage modulus and G4 is a loss modulus, and the storage modulus G1 and the loss modulus G2 are measured at 80° C. when the toner is heated from 70° C. to 150° C. and the storage modulus G3 and the loss modulus G4 are measured at 80° C. when the toner heated to 150° C. is cooled to 70° C.
摘要:
A toner for developing an electrostatic image, including: toner base particles each including a binder resin and a releasing agent; and inorganic fine particles, wherein the toner includes the inorganic fine particles as an external additive on a surface of the toner base particle, wherein the toner base particles have a BET specific surface area of 2.5 m2/g to 5.0 m2/g, and wherein the inorganic fine particles comprise inorganic fine particles (A) which are each a secondary particle where a plurality of primary particles are coalesced together.
摘要:
A method of treating a disease associated with angiogenesis by administering a therapeutically effective amount of a compound represented by the formula (1) or a salt thereof wherein the ring X represents R1 and R2 independently represent a hydrogen atom, an alkyl, an aryl or an aromatic heterocyclic; R3 represents a hydrogen atom, a halogen atom, a hydroxy, an alkoxy, an aryloxy, an alkyl, an aryl, an amino, an alkylamino, a cycloalkylamino, an arylamino, an alkylcarbonylamino, an arylcarbonylamino, a mercapto, an alkylthio, an arylthio, an alkylsulfinyl or a nonaromatic heterocyclic; A1 represents a sulfur atom, a sulfinyl or a sulfonyl; and A2 represents an alkylene.
摘要翻译:通过施用治疗有效量的由式(1)表示的化合物或其盐来治疗与血管生成相关的疾病的方法,其中环X表示R 1和R 2独立地表示氢原子,烷基,芳基或 芳香杂环; R 3表示氢原子,卤素原子,羟基,烷氧基,芳氧基,烷基,芳基,氨基,烷基氨基,环烷基氨基,芳基氨基,烷基羰基氨基,芳基羰基氨基,巯基,烷硫基 芳硫基,烷基亚磺酰基或非芳族杂环; A1表示硫原子,亚磺酰基或磺酰基; A2表示亚烷基。
摘要:
To provide a toner, which contains: toner base particles each containing a binder resin and a colorant; and an external additive containing inorganic particles and fatty acid metal salt particles, wherein the inorganic particles contain at least hydrophobic silica particles, wherein a liberation ratio Ya of the hydrophobic silica particles from the toner is 1% by mass to 20% by mass, and wherein a libration ratio Yb of the fatty acid metal salt particles from the toner is 30% by mass to 90% by mass.
摘要:
To provide a toner A containing: base particles, each containing polyester, microcrystalline wax, and a colorant; and spherical silica particles having an average primary particle diameter of 100 nm to 150 nm, wherein the microcrystalline wax has an onset temperature of 45° C. to 60° C. as determined by DSC, and a carbon number distribution of 25 to 55.